Therefore, we suggest that the marked differences in the survival outcome of CRC patients are at least partially based on genome instability, which occurs due to the failures of the genome stability pathways, of which KIF11 and KIF14 seem to be important players. Here, KIF11 is linked to colorectal carcinoma.